share_log

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

Ardelyx | 4:持股变动声明-高管 Williams Laura A
美股SEC公告 ·  08/22 18:45

Moomoo AI 已提取核心信息

Ardelyx's Chief Medical Officer, Laura A. Williams, completed a sale of 7,412 shares of common stock on 08/20/2024. The transaction was executed at a price of $5.8603 per share, resulting in a total sale value of $43,436.54. Following the sale, Williams holds a total of 314,740 Ardelyx shares directly. The sale took place in an open market or private sale, as per the transaction code description.
Ardelyx's Chief Medical Officer, Laura A. Williams, completed a sale of 7,412 shares of common stock on 08/20/2024. The transaction was executed at a price of $5.8603 per share, resulting in a total sale value of $43,436.54. Following the sale, Williams holds a total of 314,740 Ardelyx shares directly. The sale took place in an open market or private sale, as per the transaction code description.
Ardelyx的首席医务官Laura A. Williams于2024年08月20日出售了7,412股普通股,成交价为每股5.8603美元,总销售金额为43,436.54美元。此次交易后,Williams直接持有314,740股Ardelyx股票。根据交易代码说明,此次销售是在公开市场或私下交易中进行的。
Ardelyx的首席医务官Laura A. Williams于2024年08月20日出售了7,412股普通股,成交价为每股5.8603美元,总销售金额为43,436.54美元。此次交易后,Williams直接持有314,740股Ardelyx股票。根据交易代码说明,此次销售是在公开市场或私下交易中进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息